Independent

[flipper44]

More Cowbell

On April 3, 2025, when Ex was beginning to ring the final death bell for DCVax-L’s maa timeline; surprisingly, MHRA guidelines increased the potential clock off time, allowing companies to respond during the process, by well over six months.

Now, 120 days later, Ex was found rummaging around for his cowbell, and aspiringly plays don’t fear the reaper, whilst, on the other hand, softly concedes there is still likely more time for response and review.

Nobody would guess the red carpet of time was extended solely for one particular autologous vaccine, nobody would dare to suggest the ECA guidelines are right now being passed through to help substantiate a new regulatory paradigm related to such, sorry, I digress,but nobody would point out DCVax-l now has ten years of data available to submit to NICE, and perhaps another legitimate control arm about to mature in an unrelated trial…

Anyway, I hope things go well these next 60 days. The birth of a powerful treatment platform for patients hangs in the balance.